Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2016 Financial Results Conference Call and Webcast
February 22 2017 - 8:00AM
Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical
company focused on the development of therapeutics for central
nervous system (CNS) disorders, today announced that it will host a
conference call and live webcast discussion at 8:30 a.m. Eastern
Time on Wednesday, March 1, 2017, to provide a corporate update and
discuss details of the Company's financial results for the quarter
and year ended December 31, 2016.
To access the live conference call via phone, dial 1-(844)
835-6563. The International dial-in number is 1-(970) 315-3916. The
conference ID number for the live call is 72927263.
The live and archived webcast can be accessed under "Events
& Presentations" in the Investor Relations section of the
Company's website at www.intracellulartherapies.com. Please
log in approximately 5-10 minutes prior to the event to register
and to download and install any necessary software.
About Intra-Cellular TherapiesIntra-Cellular
Therapies is developing novel drugs for the treatment of
neuropsychiatric and neurodegenerative diseases and diseases of the
elderly, including Parkinson's and Alzheimer's disease. The Company
is developing its lead drug candidate, lumateperone, for the
treatment of schizophrenia, bipolar disorder, behavioral
disturbances in patients with dementia, including Alzheimer's
disease, depression and other neuropsychiatric and neurological
disorders. Lumateperone, a first-in-class molecule, is in Phase 3
clinical development for the treatment of schizophrenia, bipolar
depression and agitation associated with dementia, including
Alzheimer's disease. The Company is also utilizing its
phosphodiesterase platform and other proprietary chemistry
platforms to develop drugs for the treatment of CNS and other
disorders.
CONTACT:
Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D.
Vice President, Corporate Communications and Investor Relations
646-440-9333
Burns McClellan, Inc.
Lisa Burns
Justin Jackson (Media)
jjackson@burnsmc.com
212-213-0006
Intra Cellular Therapies (NASDAQ:ITCI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Intra Cellular Therapies (NASDAQ:ITCI)
Historical Stock Chart
From Apr 2023 to Apr 2024